Rivaskirby6153

The first topic concerns the indication for anticoagulant therapy in patients with subclinical AF revealed by implanted devices. The second issue examines the opportunity to use NOACs in oncological patients with AF. The third gap evaluates the necessity of anticoagulating patients with AF and CHA2DS2-VASc 1 or CHA2DS2-VASc 2 if women. The last "gap in evidence" concerns the preference of triple or double therapy in patients with AF and acute coronary syndrome/coronary stenting. The work has also been implemented with evidences deriving from important randomized studies published after the date of the Conference.BACKGROUND Clozapine, an antipsychotic medication, can ordinarily cause gastrointestinal hypomotility, but clozapine-related Ogilvie Syndrome (colonic pseudo-obstruction) has been reported rarely. CASE REPORT A 29-year-old male was admitted to the emergency department (ED) with complaints of vomiting, abdominal pain, and distension lasting for a day. He was on clozapine therapy due to schizophrenia. An abdominal-CT scan revealed dilation from the cecum to the ileum and he was diagnosed with Ogilvie syndrome. During the observation period in the ED, respiratory distress, hypotension, and alteration in consciousness were observed, and the patient was intubated electively. Arterial blood gas showed primary metabolic acidosis, with a normal anion gap with full respiratory compensation. In the control CT scan there was no visible perforation but distension persisted; the cecum diameter was 93 mm and the colonic wall was thickened. After the CT scan, the patient went into cardiac arrest and died 13 hours after his admission. In this case, excessive colonic dilatation, high WBC, and lactate levels and increased thickness of the colon wall suggest sepsis due to intestinal ischemia. CONCLUSIONS Clozapine-related gastrointestinal hypomotility (CRGH) is not a trivial symptom. It can cause Ogilvie syndrome, which can be fatal due to complications. In the current clozapine prescription content, information on CRGH is insufficient. Higher levels of suspicion, lower diagnostic thresholds in the case of mental and psychiatric patients may prevent delays in diagnosis and treatment and result in lower mortality.PURPOSE The aim of this research was to assess the prevalence of Night Eating Syndrome (NES) in a university student population and to clear up the relationship between NES, depression and chronotype. The relation between NES and seasonality was also investigated. METHODS The data were collected from a sample of 1136 students of the L'Aquila University, Italy. All subjects were invited to answer to the Sociodemographic Information Form and to take a self-report battery composed by four questionnaires the Night Eating Questionnaire (NEQ), the Morningness Eveningness Questionnaire (MEQ), the Seasonal Pattern Assessment Questionnaire (SPAQ) and the Beck Depression Inventory (BDI). RESULTS The 5.3% of our population (60 subjects) reached the criteria for NES. The distribution of chronotypes in the sample was Morning Type 15.3%, Intermediate 64.3% and Evening Type 20.4%. The 36.7% of the participants reaching the criteria for NES, obtained low scores on the MEQ. The data indicated that NEQ and MEQ scores are signi Nervosa (BN) and Binge Eating Disorder (BED), night eating symptoms may vary significantly across the seasons; subjects with NES experience seasonal variation in their mood and in their eating patterns.INTRODUCTION Most psychotropic drugs are effective for several mental disorders, rather than for specific diagnoses. ALK inhibitor The dimensional approach to psychiatric nosology can explain the non-specificity of drug action, and it could usefully integrate the traditional categorical approach and may help optimize personalised psychiatric treatment. This study aimed at examining the use of antiepileptic drugs, particularly valproate, for the treatment of prominent aggression, impulsivity, and activation, within the conceptual framework of a "dimensional pharmacotherapy" strategy. METHODS This observational, naturalistic study included 846 adult psychiatric inpatients. Within 48 hours from admission and then again at discharge, each patient was administered the Brief Psychiatric Rating Scale (BPRS) and the SVARAD scale for rapid dimensional assessment. RESULTS We found a statistically significant association between the prescription of an antiepileptic drug (valproate in the vast majority of cases) and the presence of high levels of aggression, impulsivity, and activation. In patients with high levels of these psychopathological dimensions, the prescription of an antiepileptic drug was significantly associated with a greater decrease in BPRS total score from admission to discharge. This finding remained significant after the exclusion of patients experiencing a manic or mixed episode. CONCLUSIONS Although methodological limitations dictate caution in interpreting our results, these preliminary findings suggest that a "dimensional pharmacotherapy" strategy (i.e., selecting drugs based on neurobiological action rather than categorical diagnosis) for the treatment of aggression, impulsivity and activation is commonly used in daily practice and may lead to greater clinical improvement, in the absence of severe adverse effects.BACKGROUND Suicide is a leading cause of death worldwide, with several risk factors, including a family history of mental disorders (FHMD) and interpersonal violence. The relationship between these risk factors needs further investigation. AIM Addressing the impact of interpersonal violence on suicide attempts, and its interaction with FHMD. METHODS 192 participants completed an online questionnaire, including the Psychological Maltreatment Review and the Karolinska Interpersonal Violence Scale (putative mediating variables variables), questions about previous suicide attempts and FHMD. Logistic regression and mediation analysis were performed. RESULTS FHMD (OR=7.09, 95%CI [2.20,22.81]), expressed violence in childhood (OR=2.55, 95%CI [1.26,5.18]) and exposure to violence in childhood (OR=2.80, 95%CI [1.80,4.34]) predicted attempted suicide. Exposure to, and expression of violence in childhood mediated 15.23% and 9.63% respectively of the total effect of FHPD on attempted suicide. LIMITATIONS Small sample size, reporting bias on FHMD an attempted suicide, self-selection bias due to sampling technique.